Please login to the form below

Not currently logged in
Email:
Password:

Oculeve

This page shows the latest Oculeve news and features for those working in and with pharma, biotech and healthcare.

Allergan stumps up $375m for bolt-on acquisitions

Allergan stumps up $375m for bolt-on acquisitions

Allergan's acquisitive streak shows no signs of abating, with the company adding two migraine drugs from Merck &Co and eye disease specialist Oculeve to its portfolio in the last few ... Meanwhile, the Oculeve deal "adds novel, complementary dry eye

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

AI and genomics: a revolution in drug discovery and development
...
Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....

Infographics